Method Development for Determining Prekallikrein Activator in Medicinal Preparations of Human Immunoglobulins and Albumin


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Method development for determining prekallikrein activator in medicinal preparations of human immunoglobulins and albumin found that the adequacy of chromogenic determination of prekallikrein activator depends on the activity of the used prekallikrein reagent, the quantitative component ratio in the reaction mixture and its incubation time, and the concentration of employed chromogenic reagent. Acceptance criteria for commercial prekallikrein reagents are justified. The main method parameters and validation test results confirming the linearity in the range 0 – 35 IU/mL, accuracy, and intralaboratory precision are presented and correspond to those for biological analytical methods. The elaborated method can be used for quality assessment of prekallikrein activator content in medicinal preparations of human immunoglobulins and albumin.

作者简介

O. Kornilova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051

M. Krivykh

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051

E. Konovalova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051

I. Borisevich

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051

补充文件

附件文件
动作
1. JATS XML

版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019